 |
|
|
Nurofen for Children (Orange Flavour) 200ml |
|
Nurofen for Children is an ibuprofen suspension that starts to work directly at the source of pain and fever to help ease your child’s discomfort, fast. And thanks to its orange or strawberry flavour, it even tastes great, making it easier to give. Nurofen for Children is also the only children’s ibuprofen medicine to come with an easy-dosing syringe in every bottle pack!
Product information leaflet:
http://emc.medicines.org.uk/medicine/20102/SPC/Nurofen for Children/
|
|
Ibuprofen 100mg/5ml (equivalent to 2.0% w/v).
Oral suspension
Prescription and OTC: For the fast and effective reduction of fever, including post immunisation pyrexia and the fast and effective relief of mild to moderate pain, such as a sore throat, teething pain, toothache, earache, headache, minor aches and sprains
|
|
Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms (see section 4.4).
For pain and fever: The daily dosage of Nurofen For Children is 20-30 mg/kg bodyweight in divided doses. Using the spoon or syringe dosing device provided this can be achieved as follows:
Infants 3 - 6 months weighing more than 5kg: One 2.5ml dose may be taken 3 times in 24 hours. Infants 6 - 12 months: One 2.5ml dose may be taken 3 to 4 times in 24 hours. Children 1 - 3 years: One 5ml dose may be taken 3 times in 24 hours.
Children 4 - 6 years: 7.5ml (5ml +2.5ml spoonful) may be taken 3 times in 24 hours. Children 7 - 9 years: Two 5ml doses may be taken 3 times in 24 hours. Children 10 – 12 years: Three 5ml doses may be taken 3 times in 24 hours.
Doses should be given approximately every 6 to 8 hours, (or with a minimum of 4 hours between each dose if required).
Not suitable for children under 3 months of age unless advised by your doctor.
For Juvenile Rheumatoid Arthritis: The usual daily dosage is 30 to 40 mg/kg/day in three to four divided doses.
For post immunisation pyrexia: One 2.5 ml dose followed by one further 2.5 ml dose 6 hours later if necessary. No more than two 2.5ml doses in 24 hours. If the fever is not reduced, consult your doctor.
For oral administration.
For short term use only. If the child's (aged over 6months) symptoms persist for more than 3 days, consult your doctor. For children under 6 months medical advice should be sought after 24 hours use (3 doses) if the symptoms persist.
|
|
Hypersensitivity to ibuprofen or any of the constituents in the product.
Patients who have previously shown hypersensitivity reactions (e.g. asthma, rhinitis, angioedema or urticaria) in response to aspirin or other non-steroidal anti-inflammatory drugs.
Active or previous peptic ulcer .
History of upper gastrointestinal bleeding or perforation, related to previous NSAIDs therapy.
Use with concomitant NSAIDs including cyclo-oxygenase-2 specific inhibitors (See section 4.5 Interactions).
Severe hepatic failure, renal failure or heart failure (See section 4.4, Special warnings and precautions for use)
Last trimester of pregnancy (See section 4.6 Pregnancy and lactation).
Severe heart failure.
|
|
Bronchospasm may be precipitated in patients suffering from or with a previous history of bronchial asthma or allergic disease.
Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms (see section 4.2, and GI and cardiovascular risks below).
The elderly are at increased risk of the serious consequences of adverse reactions.
Systemic lupus erythematosus and mixed connective tissue disease - increased risk of aseptic meningitis (see section 4.8 Undesirable effects)
Chronic inflammatory intestinal disease (ulcerative colitis, Crohn's disease) – as these conditions may be exacerbated (See section 4.8 Undesirable effects).
Hypertension and/or cardiac impairment as renal function may deteriorate and/or fluid retention occur.
Renal impairment as renal function may further deteriorate (See section 4.3 Contraindications and Section 4.8 Undesirable effects)
Hepatic dysfunction (See section 4.3 Contraindications and Section 4.8 Undesirable effects)
There is limited evidence that drugs which inhibit cyclo-oxygenase/ prostaglandin synthesis may cause impairment of female fertility by an effect on ovulation. This is reversible upon withdrawal of treatment.
GI bleeding, ulceration or perforation, which can be fatal, has been reported with all NSAIDs at anytime during treatment, with or without warning symptoms or a previous history of serious GI events.
Patients with a history of GI toxicity, particularly when elderly, should report any unusual abdominal symptoms (especially GI bleeding) particularly in the initial stages of treatment.
Caution should be advised in patients receiving concomitant medications which could increase the risk of gastrotoxicity or bleeding, such as corticosteroids, or anticoagulants such as warfarin or anti-platelet agents such as aspirin (see section 4.5 Interactions).
When GI bleeding or ulceration occurs in patients receiving ibuprofen, the treatment should be withdrawn.
For OTC: Caution (discussion with doctor or pharmacist) is required prior to starting treatment in patients with a history of hypertension and/or heart failure as fluid retention, hypertension and oedema have been reported in association with NSAID therapy.
Cardiovascular and cerebrovascular effects
Clinical trial and epidemiological data suggest that use of ibuprofen, particularly at high doses (2400mg daily) and in long-term treatment may be associated with a small increased risk of arterial thrombotic events (for example myocardial infarction or stroke). Overall, epidemiological studies do not suggest that low dose ibuprofen (e.g. 1200mg daily) is associated with an increased risk of myocardial infarction.
|
|
|
